67. Nat Commun. 2018 Apr 9;9(1):1340. doi: 10.1038/s41467-018-03178-z.Genome-wide association study identifies susceptibility loci for B-cell childhoodacute lymphoblastic leukemia.Vijayakrishnan J(1), Studd J(1), Broderick P(1), Kinnersley B(1), Holroyd A(1),Law PJ(1), Kumar R(2), Allan JM(3), Harrison CJ(4), Moorman AV(4), Vora A(5),Roman E(6), Rachakonda S(2), Kinsey SE(7), Sheridan E(8), Thompson PD(9), Irving JA(3), Koehler R(10), Hoffmann P(11)(12), Nöthen MM(11), Heilmann-Heimbach S(11),Jöckel KH(13), Easton DF(14)(15), Pharaoh PDP(14)(15), Dunning AM(16), PetoJ(17), Canzian F(18), Swerdlow A(1)(19), Eeles RA(1)(20), Kote-Jarai Z(1), MuirK(21)(22), Pashayan N(15)(23), Greaves M(24), Zimmerman M(25), Bartram CR(10),Schrappe M(26), Stanulla M(25), Hemminki K(2)(27), Houlston RS(28); PRACTICALConsortium.Collaborators: Henderson BE, Haiman CA, Benlloch S, Schumacher FR, Olama AAA,Berndt SI, Conti DV, Wiklund F, Chanock S, Stevens VL, Tangen CM, Batra J,Clements J, Gronberg H, Schleutker J, Albanes D, Weinstein S, Wolk A, West C,Mucci L, Cancel-Tassin G, Koutros S, Sorensen KD, Maehle L, Neal DE, Travis RC,Hamilton RJ, Ingles SA, Rosenstein B, Lu YJ, Giles GG, Kibel AS, Vega A,Kogevinas M, Penney KL, Park JY, Stanford JL, Cybulski C, Nordestgaard BG,Brenner H, Maier C, Kim J, John EM, Teixeira MR, Neuhausen SL, De Ruyck K, RazackA, Newcomb LF, Lessel D, Kaneva R, Usmani N, Claessens F, Townsend PA, Dominguez MG, Roobol MJ, Menegaux F.Author information: (1)Division of Genetics and Epidemiology, The Institute of Cancer Research,Sutton, Surrey, SM2 5NG, UK.(2)Division of Molecular Genetic Epidemiology, German Cancer Research Centre,69120, Heidelberg, Germany.(3)Northern Institute for Cancer Research, Newcastle University, Newcastle uponTyne, NE2 4HH, UK.(4)Wolfson Childhood Cancer Research Centre, Northern Institute for CancerResearch, Newcastle University, Newcastle upon Tyne, NE1 7RU, UK.(5)Department of Haematology, Great Ormond Street Hospital, London, WC1N 3JH, UK.(6)Department of Health Sciences, University of York, York, YO10 5DD, UK.(7)Department of Paediatric and Adolescent Haematology and Oncology, LeedsGeneral Infirmary, Leeds, LS1 3EX, UK.(8)Medical Genetics Research Group, Leeds Institute of Molecular Medicine,University of Leeds, Leeds, LS9 7TF, UK.(9)Paediatric and Familial Cancer Research Group, Institute of Cancer Sciences,St. Mary's Hospital, Manchester, M13 9WL, UK.(10)Department of Human Genetics, Institute of Human Genetics, University ofHeidelberg, 69120, Heidelberg, Germany.(11)Department of Genomics, Institute of Human Genetics, Life & Brain Centre,University of Bonn, D-53012, Bonn, Germany.(12)Department of Biomedicine, Human Genomics Research Group, University Hospitaland University of Basel, 4031, Basel, Switzerland.(13)Institute for Medical Informatics, Biometry and Epidemiology, UniversityHospital Essen, University of Duisburg-Essen, 45147, Essen, Germany.(14)Department of Oncology, Centre for Cancer Genetic Epidemiology, University ofCambridge, Cambridge, CB1 8RN, UK.(15)Department of Public Health and Primary Care, Centre for Cancer GeneticEpidemiology, University of Cambridge, Cambridge, CB1 8RN, UK.(16)Department of Oncology, Centre for Cancer Genetic Epidemiology, University ofCambridge, Strangeways Laboratory, Cambridge, CB1 8RN, UK.(17)Department of Non-Communicable Disease Epidemiology, London School of Hygieneand Tropical Medicine, London, WC1E 7HT, UK.(18)Genomic Epidemiology Group, German Cancer Research Center (DKFZ), 69120,Heidelberg, Germany.(19)Division of Breast Cancer Research, The Institute of Cancer Research, London,SW7 3RP, UK.(20)Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK.(21)Institute of Population Health, University of Manchester, Manchester, M139PL, UK.(22)Warwick Medical School, University of Warwick, Coventry, CV4 7AL, UK.(23)Department of Applied Health Research, University College London, London,WC1E 7HB, UK.(24)Centre for Evolution and Cancer, Institute of Cancer Research, Sutton,Surrey, SM2 5NG, UK.(25)Department of Paediatric Haematology and Oncology, Hannover Medical School,30625, Hannover, Germany.(26)General Paediatrics, University Hospital Schleswig-Holstein, 24105, Kiel,Germany.(27)Center for Primary Health Care Research, Lund University, 221 00, Lund,Sweden.(28)Division of Genetics and Epidemiology, The Institute of Cancer Research,Sutton, Surrey, SM2 5NG, UK. richard.houlston@icr.ac.uk.Genome-wide association studies (GWAS) have advanced our understanding ofsusceptibility to B-cell precursor acute lymphoblastic leukemia (BCP-ALL);however, much of the heritable risk remains unidentified. Here, we perform a GWASand conduct a meta-analysis with two existing GWAS, totaling 2442 cases and14,609 controls. We identify risk loci for BCP-ALL at 8q24.21 (rs28665337,P = 3.86 × 10-9, odds ratio (OR) = 1.34) and for ETV6-RUNX1 fusion-positiveBCP-ALL at 2q22.3 (rs17481869, P = 3.20 × 10-8, OR = 2.14). Our findings provide further insights into genetic susceptibility to ALL and its biology.DOI: 10.1038/s41467-018-03178-z PMCID: PMC5890276PMID: 29632299 